Form D · Pharmaceuticals

Viamet Pharmaceuticals Inc

Morrisville, NC · CIK 0001336674

Offering snapshot reported Feb 18, 2011 · SEC filing

Reported sold
$25M
Offering amount: $25M
Investors reported
7
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 23, 2009
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$12.5M$25MJul 7, 2009: $9,999,997.00Jul 7, 2009Feb 18, 2011: $24,999,997.00Feb 18, 2011

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$9,999,997 → $24,999,997

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 18, 2011Amendment$24,999,997$15,000,000vs Jul 7, 20097SEC filing
Jul 7, 2009Initial$9,999,997No comparison7SEC filing
Aug 6, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Jun 6, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Feb 14, 2006PaperNot reportedNo comparisonNot reportedSEC filing
Aug 18, 2005PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-80342

Source: Form D, filed Feb 18, 2011. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Garheng Kong Director
Neil Moore Executive
Douglas Reed Director
James Rosen Director
Robert Schotzinger Director, Executive
Lauren Silverman Director
S. Edward Torres Director
Andrew Von Eschenbach Director
William T. White, Iii Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
2250 Perimeter Park Drive Suite 320
Morrisville, NC, 27560